Observatorio de I+D+i UPM

Go Back | Technology Solutions

GLOTTEX. Your voice treats you, your voice identifies you

More info

[Glottex]Commercial_Sheet_UPM_EN(Innovatech) PDF

Innovative biometric application for the early detection of voice pathology and security.

Glottex Voice Analysis System® is an advanced voice analysis product for the biometrics identification, result of over 15 years of R&D of a team from the School of Computing of the Technical University of Madrid.

In its health version, is currently applied for the early detection of pathologies voice and laryngeal cancer, as well as medical treatment and rehabilitation, in different hospitals in Madrid. Another line of development with high-impact is based on the identification of initial symptoms of neurological diseases such as Alzheimer or Parkinson. Moreover, and as a security application, Glottex is used by one of the Spanish security forces for forensic identification by voice.

Technology Solution

IdentificationGlottex Voice Analysis System®, Glottex onwards, is a software application for advanced analysis of the voice and the determination of the sample closest to the biometric voiceprint. 

This new solution identifies, with much more reliability, unique voice characteristics distinguishing those derived from the vocal tract (pharynx, oral cavity, nasal cavity) from those of the excitation source of the voice. Glottex is able to assess and extract unique physiological parameters from the glottal source - part of the larynx that is limited by the vocal cords and whose vibration generates the voice - . 

This represents a unique technological solution able to identify early detection for voice pathology, its treatment or even identify a person biometrically

Market demands

  • Voice disorders affect 5% of the world population, with a higher incidence among young people and professional groups dependent on the use of voice. Early detection is a key factor for treatment.
  • Laryngeal cancer affected 150.000 persons in 2008, with a very out-standing degree of mortality and incidence increasing (Spain, at the top European level). The hoarseness of voice is one of the main symptoms of this cancer.
  • According to the World Health Organization, an estimated population of 6.8 million people worldwide dies each year as a result of neurological disorders.
  • A global interest increasing for trustworthy biometric solutions and of difficult impostation (new and sophisticated threats for the safety).
  • The safe management of digital identity is critical in numerous niche markets, with sales volumes rising (e.g. mobile banking).
  • The security and intelligence departments analyze conversations related to crimes with increasing frequency. Nowadays, it is more difficult to identify suspects with traditional methods
Market potential

  • Demand for new innovative and low-cost methods for diagnosis diseases
  • European medical technology industry (2007): € 72.6 billion sales revenues; 15% annual growth rate [Eucomed]. 
  • The turnover associated with voice biometrics is doubled in the period 2011-2014. This year, it is expected a volume of $ 260 million market with a market share growth of 16% [Opus Research].
  • Innovative technological advances have relaunched the evolution of forensic research sector through a better cost.
  • The market for forensic products and services in the U.S. represent $ 10.3 thousand million [BCC Research].
Competitive advantages

  • Support for reliable and early detection of voice pathology through a pioneer analysis based on scientific and technological advances.
  • R&D ongoing that could allow identify early symptoms of neurological diseases prematurely.
  • Low cost of implementation in health systems: software customizable, no specific hardware requirements. 50% savings cost per patient (estimations made by medical professionals that already use Glottex)
  • Non-invasive diagnostic technique, fast and without side-effects for the patient. 50% savings in time per patient (estimations made by medical professionals that already use Glottex)
  • Maximum reliability in biometric identification of people
  • Very simple and low cost incorporation to the already existing voice equipment 
  • Biometric technology enabling remote authentication.
  • Positive market research regarding the acceptance of biometric technology users.



  • Hospital Gregorio Marañón, Madrid.
  • Spanish Guardia Civil.

  • Patent granted in Spain ES2364401
  • International patent applied via PCT  PCT/ES2012/000137-WO2013001109.
  • Patent applied in USA US 14/127,202
  • Registered software M-006038/2008 by the Technical University of Madrid.


Development stage

  • Concept
  • R&D
  • Lab-Protoype
  • Industrial Prototype
  • Production

Glottex contact (spin-off BiometroSoft )

Pedro Gómez Vilda, Victoria Rodellar Biarge

e: pedro@pino.datsi.fi.upm.es

UPM contact

Innovation, Commercialization and Entrepreneurship Area

Centre of Support for Technological Innovation – UPM 

e: innovacion.tecnologica@upm.es

S2i 2021 Observatorio de investigación @ UPM con la colaboración del Consejo Social UPM
Cofinanciación del MINECO en el marco del Programa INNCIDE 2011 (OTR-2011-0236)
Cofinanciación del MINECO en el marco del Programa INNPACTO (IPT-020000-2010-22)